EPITOPE SUMMARY | |
---|---|
piperacillin (epitope ID ) has this structure: . The epitope has these synonyms: 6beta-{(2R)-2-[(4-ethyl-2,3-dioxopiperazin-1-yl)carboxamido]-2-phenylacetamido}-2,2-dimethylpenam-3alpha-carboxylic acid, (2S,5R,6R)-6-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, piperacillin, Piperacillin, Piperacillin anhydrous. This epitope has been studied for immune reactivity in publication(s), tested in T cell assays and B cell assays. |
CURATED EXPERIMENTAL DATA | |
---|---|
B Cell Assay(s) | |
Assay Type | Positive / All |
qualitative binding | / |
hypersensitivity | / |
T Cell Assay(s) | |
Assay Type | Positive / All |
proliferation | / |
IL-13 release | / |
IFNg release | / |
cytotoxicity | / |
IL-4 release | / |
IL-5 release | / |
TNFa release | / |
CCL4/MIP-1b release | / |
IL-10 release | / |
IL-1b release | / |
EXTERNAL RESOURCES | |
---|---|
Resource | Link |